OPKO Health Management
Management criteria checks 2/4
OPKO Health's CEO is Phil Frost, appointed in Mar 2007, has a tenure of 17.67 years. total yearly compensation is $2.28M, comprised of 42.2% salary and 57.8% bonuses, including company stock and options. directly owns 35.96% of the company’s shares, worth €370.06M. The average tenure of the management team and the board of directors is 9.7 years and 15.6 years respectively.
Key information
Phil Frost
Chief executive officer
US$2.3m
Total compensation
| CEO salary percentage | 42.2% |
| CEO tenure | 17.7yrs |
| CEO ownership | 36.0% |
| Management average tenure | 9.7yrs |
| Board average tenure | 15.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$134m |
| Jun 30 2024 | n/a | n/a | -US$243m |
| Mar 31 2024 | n/a | n/a | -US$252m |
| Dec 31 2023 | US$2m | US$960k | -US$189m |
| Sep 30 2023 | n/a | n/a | -US$208m |
| Jun 30 2023 | n/a | n/a | -US$209m |
| Mar 31 2023 | n/a | n/a | -US$291m |
| Dec 31 2022 | US$972k | US$960k | -US$328m |
| Sep 30 2022 | n/a | n/a | -US$317m |
| Jun 30 2022 | n/a | n/a | -US$202m |
| Mar 31 2022 | n/a | n/a | -US$117m |
| Dec 31 2021 | US$2m | US$960k | -US$30m |
| Sep 30 2021 | n/a | n/a | US$76m |
| Jun 30 2021 | n/a | n/a | US$71m |
| Mar 31 2021 | n/a | n/a | US$121m |
| Dec 31 2020 | US$2m | US$960k | US$31m |
| Sep 30 2020 | n/a | n/a | -US$114m |
| Jun 30 2020 | n/a | n/a | -US$200m |
| Mar 31 2020 | n/a | n/a | -US$293m |
| Dec 31 2019 | US$1m | US$960k | -US$315m |
| Sep 30 2019 | n/a | n/a | -US$279m |
| Jun 30 2019 | n/a | n/a | -US$244m |
| Mar 31 2019 | n/a | n/a | -US$191m |
| Dec 31 2018 | US$2m | US$960k | -US$153m |
| Sep 30 2018 | n/a | n/a | -US$295m |
| Jun 30 2018 | n/a | n/a | -US$303m |
| Mar 31 2018 | n/a | n/a | -US$314m |
| Dec 31 2017 | US$971k | US$960k | -US$305m |
Compensation vs Market: Phil's total compensation ($USD2.28M) is above average for companies of similar size in the German market ($USD1.46M).
Compensation vs Earnings: Phil's compensation has increased whilst the company is unprofitable.
CEO
Phil Frost (88 yo)
17.7yrs
Tenure
US$2,277,200
Compensation
Dr. Phillip Frost, also known as Phil, M.D., Ph D., is Director of Non-Invasive Monitoring Systems, Inc. since June 01, 2023. He has been the Chairman, Chief Executive Officer and Director of OPKO Health,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 17.7yrs | US$2.28m | 35.96% € 370.1m | |
| Vice Chairman & Chief Technical Officer | 17.8yrs | US$2.19m | 4.85% € 50.0m | |
| President & Vice Chairman | 2.5yrs | US$2.19m | 2.99% € 30.8m | |
| Senior VP | 17.7yrs | US$1.81m | 0.026% € 270.2k | |
| Executive VP of Administration & Director | 17.5yrs | US$1.94m | 0.91% € 9.3m | |
| Senior Vice President of Clinical Research & Development and Medical Affairs - Opko Renal | 7.7yrs | no data | no data | |
| Chief Innovation Officer & Director | 2.5yrs | no data | 5.91% € 60.8m | |
| Chief Medical Officer | less than a year | no data | no data | |
| Chief Executive Officer of OPKO Renal | 11.7yrs | no data | no data | |
| President of Transition Therapeutics | no data | no data | no data | |
| President of OPKO Health Iberoamerica | no data | no data | no data | |
| Chief Executive Officer of EirGen Pharma | 5yrs | no data | no data |
9.7yrs
Average Tenure
71.5yo
Average Age
Experienced Management: XCY's management team is seasoned and experienced (9.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 17.7yrs | US$2.28m | 35.96% € 370.1m | |
| Vice Chairman & Chief Technical Officer | 17.8yrs | US$2.19m | 4.85% € 50.0m | |
| President & Vice Chairman | 2.5yrs | US$2.19m | 2.99% € 30.8m | |
| Executive VP of Administration & Director | 17.8yrs | US$1.94m | 0.91% € 9.3m | |
| Chief Innovation Officer & Director | 2.5yrs | no data | 5.91% € 60.8m | |
| Independent Director | 3.9yrs | US$69.90k | 0% € 0 | |
| Lead Independent Director | 16.8yrs | US$134.80k | 0.048% € 490.1k | |
| Independent Director | 7.8yrs | US$92.40k | 0.015% € 155.8k | |
| Independent Director | 20.9yrs | US$84.90k | 0.058% € 593.4k | |
| Independent Director | 3.7yrs | US$92.40k | 0% € 0 | |
| Independent Director | 15.6yrs | US$62.40k | 0.0097% € 100.2k |
15.6yrs
Average Tenure
77yo
Average Age
Experienced Board: XCY's board of directors are seasoned and experienced ( 15.6 years average tenure).